Current perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension

Despite our achievements in modern medicine, arterial hypertension (AH) remains one of the main causes of fatal complications, such as myocardial infarction and acute cerebrovascular accident leading to disability and mortality of patients, including those of working age. The prevalence of hypertension is significantly higher among old and senile age population, however, it has recently tended to increase in young and middle-aged people. Thus, the Russian epidemiological ESSE-RF study, in which representative sample of the Russian population aged 25–64 years were studied, showed that the prevalence of hypertension in individuals of that age group was 44%. It was predicted that the world’s burden of hypertension would increase by 15–20% to approximately 1.5 million people in the year 2015. Due to the high incidence of hypertension and complications associated with hypertension development, further study of pathogenetic mechanisms, development of diagnostic examination methods, prophylactic measures and the search for new treatment options with fixed-dose combination drugs is an important area of modern medicine. This article provides an overview of clinical studies of the components (lisinopril and indapamide) of a rational ACE inhibitor–diuretic combination and a clinical example.

arterial hypertension, blood pressure, antihypertensive therapy, combination antihypertensive therapy, lisinopril, indapamide

1. Boytsov S.A., Balanova Yu.A., Shalnova S.A. Deev A.D., Artamonova G.V., Gatagonova T.M., Duplyakov D.V., Efanov A.Y., Zhernakova Y.V., Konradi A.O., Libis R.A., Minakov A.V., Nedogoda S.V., Oshchepkova E.V., Romanchuk S.A., Rotar O.P., Trubacheva I.A., Chazova I.E., Shlyakhto E.V., Muromtseva G.A., Evstifeeva S.E., Kapustina A.V., Konstantinov V.V., Oganov R.G., Mamedov M.N., Baranova E.I., Nazarova O.A., Shutemova O.A., Furmenko G.I., Babenko N.I., Azarin O.G., Bondartsov L.V., Khvostikova A.E., Ledyaeva A.A., Chumachek E.V., Isaeva E.N., Basyrova I.R., Kondratenko V.Y., Lopina E.A., Safonova D.V., Skripchenko A.E., Indukaeva E.V., Cherkass N.V., Maksimov S.A., Danilchenko Y.V., Mulerova T.A., Shalaev S.V., Medvedeva I.V., Shava V.G., Storozhok M.A., Tolparov G.V., Astakhova Z.T., Toguzova Z.A., Kaveshnikov V.S., Karpov R.S., Serebryakova V.N. Arterial hypertension among people aged 25–64: prevalence, awareness, treatment and control. Based on the essay study. Cardiovascular therapy and prevention. 2014;13(4):4- 14. doi: 10.15829/1728-8800-2014-4-4-14.

2. Klimov A.V., Denisov E.N., Ivanova O.V. Arterial hypertension and its prevalence in the population. Molodoy uchenyy = Young scientist. 2018;50(236):86-90. (In Russ.) Available at: https://moluch.ru/archive/236/54737.

3. Drapkina O.M. Isolated systolic hypertension is the lot of elderly hypertension. Trudnyy patsient = Difficult patient. 2012;10(12):10-13. (In Russ.) Available at: http://t-pacient.ru/articles/197.

4. Parfenov V.A., Ostroumova T.M., Ostroumova O.D. Arterial hypertension and dizziness: is there a relationship? Ratsional’naya farmakoterapiya v kardiologii = Rational pharmacotherapy in cardiology. 2019;15(1):125-129. (In Russ.) doi: 10.20996/1819-6446-2019-15-1-125-129.

5. Panchenko E.P., Belenkov Yu.N. Characterization and outcomes of atherothrombosis in outpatients in the Russian Federation (based on materials from the international REACH registry). Kardiologiya = Cardiology. 2008;(2):17-24. (In Russ.) doi: 10.20996/1819-6446-2013-9-5-494-499.

6. Karpov Yu.A. Angiotensin-converting enzyme inhibitors in mono- and combination therapy of arterial hypertension. Rmzh = RMJ. 2009;17(18):1122-1126. (In Russ.) Available at: https://www.rmj.ru/articles/ kardiologiya/Ingibitory_angiotenzinprevraschayuschego__fermenta_v_mono_i_kombinirovannoy__terapii_arterialynoy_gipertonii.

7. Yudina I.Yu., Morozova T.E. The clinical use of fixed combinations of antihypertensive drugs. Lechashchiy vrach = Attending doctor. 2015;(2):8. Available at: https://www.lvrach.ru/2015/02/15436155.

8. Brunstrom M., Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Internal Medicine. 2018;178:28–36. doi: 10.1001/jamainternmed.2017.6015.

9. Ettehad D., Emdin C.A., Kiran A., Anderson S.G., Callender T., Emberson J., Chalmers J., Rodgers A., Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957– 967. doi: 10.1016/S0140-6736(15)01225-8.

10. Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: Head-to-head comparisons of various classes of antihypertensive drugs – overview and meta-analyses. Journal of Hypertension. 2015;33:1321–1341. doi: 10.1097/HJH.0000000000000447.

11. Rutten F.H., Zuithoff N.P., Halk F., Grobbee D.E., Hoes A.W. Beta-Blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Archives of Internal Medicine. 2010;170:880–887. doi: 10.1001/archinternmed.2010.112.

12. Chazova I.E., Zhernakova Yu.V. on behalf of the experts. Clinical guidelines. Diagnosis and treatment of arterial hypertension. Sistemnye gipertenzii = Systemic Hypertension. 2019;16(1):6–31. (In Russ.) doi: 10.26442/2075082X.2019.1.190179.

13. Wald D.S., Law M., Morris J.K., Bestwick J.P., Wald N.J. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. American Journal of Medicine. 2009;122:290–300. doi: 10.1016/j.amjmed.2008.09.038.

14. MacDonald T.M., Williams B., Webb D.J., Morant S., Caulfield M., Cruickshank J.K., Ford I., Sever P., Mackenzie I.S., Padmanabhan S., McCann G.P., Salsbury J., McInnes G. Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: a doubleblind randomized controlled trial. Journal of the American Heart Association. 2017;6:e006986. doi: 10.1161/JAHA.117.006986.

15. Thomopoulos C., Parati G., Zanchetti A.. Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials. Journal of Hypertension. 2016;34:1921– 1932. doi: 10.1097/HJH.0000000000001052.

16. Yusuf S., Lonn E., Pais P., Bosch J., López-Jaramillo P., Zhu J., Xavier D., Avezum A., Leiter L.A., Piegas L.S., Parkhomenko A., Keltai M., Keltai K., Sliwa K., Chazova I., Peters R.J., Held C., Yusoff K., Lewis B.S., Jansky P., Khunti K., Toff W.D., Reid C.M., Varigos .J, Accini J.L., McKelvie R., Pogue J., Jung H., Liu L., Diaz R., Dans A., Dagenais G. HOPE-3 Investigators. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. New England Journal of Medicine. 2016;374:2032–2043. doi: 10.1056/NEJMoa1600177.

17. Corrao G., Zambon A., Parodi A., Poluzzi E., Baldi I., Merlino L., Cesana G., Mancia G. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. Journal of Hypertens. 2008;26:819– 824. doi: 10.1097/HJH.0b013e3282f4edd7.

18. Britov A.N. Angiotensin-converting enzyme inhibitors in the treatment and prevention of arterial hypertension and metabolic syndrome, the place of lisinopril. Trudnyy patsient = Difficult patient. 2009;7(10):35-39. (In Russ.) Available at: http://t-pacient.ru/articles/6482.

19. Chazova I.E. Arterial hypertension in the light of current recommendations. Terapevticheskiy arkhiv = Therapeutic Archive. 2018;90(9):4-7. (In Russ.) doi: 10.26442/terarkh20189094-7.

20. Minushkina L.O. Lisinopril in the treatment of hypertension in patients with concomitant liver disease. Farmateka = Pharmateca. 2010;(5):39-44. (In Russ.) Available at: https:// pharmateca.ru/ru/archive/article/7768.

21. Podzolkov V.I., Osadchy K.K. ACE inhibitors in the treatment of hypertension: focus on lisinopril. Ratsional’naya farmakoterapiya v kardiologii = Rational pharmacotherapy in cardiology. 2009;5(1):57-62. (In Russ.) doi: 10.20996/1819- 6446-2009-5-1-57-62.

22. Volkov A.V. Lisinopril: a universal drug in the arsenal of a cardiologist. Rmzh = RMJ. 2010;18(3):145- 148. (In Russ.) Available at: https://www.rmj.ru/ articles/kardiologiya/Lizinopril_universalynyy_ preparat__v_arsenale_vracha_kardiologa.

23. Podzolkov V.I., Dragomiretskaya N.A. The use of a fixed combination of lisinopril and indapamide for optimal cardioprotection in patients with hypertension. Arterial’naya gipertenziya = Arterial hypertension. 2018;24(4):459-468. (In Russ.) doi: 10.18705/1607-419X-2018-24-4-4-459-468.

24. Barsukov A.V., Glukhovskoy D.V., Talantseva M.S., Bagaeva Z.V., Pronina E.V., Zobnina M.P., Sveklina T.S., Korovin A.E. Left ventricular hypertrophy and the renin-angiotensin-aldosterone system: AT1-angiotensin receptor blockers are in focus. Sistemnye gipertenzii = Systemic hypertension. 2013;(1):88-96. (In Russ.) Available at: https:// con-med.ru/magazines/hypertension/hypertension-01-2013/gipertrofiya_levogo_ zheludochka_i_renin_angiotenzin_aldosteronovaya_sistema_v_fokuse_blokatory_at1_a.

25. Evdokimova A.G., Evdokimov V.V., Smetanin A.V., Yunko S.A. Arterial hypertension and a high risk of cardiovascular complications: focus on lisinopril. Trudnyy patsient = Difficult patient. 2010;8(11):9-13. (In Russ.) Available at: http://tpacient.ru/articles/6598.

26. Jayani N.A. Some aspects of the use of lisinopril in arterial hypertension. Ratsional’naya farmakoterapiya v kardiologii = Rational pharmacotherapy in cardiology. 2010;6(1):95-102. (In Russ.) doi: 10.20996/1819-6446-2010-6-1-95-102.

27. Baryshnikova G.A., Stepanova I.I., Chuprova N.V. The role of angiotensin converting enzyme inhibitors in the treatment of arterial hypertension: focus on lisinopril. Lechashchiy vrach = Attending doctor. 2013;(2):13. (In Russ.) Available at: https:// www.lvrach.ru/2013/02/15435617.

28. Podzolkov V.I., Tarzimanova A.I. The importance of lisinopril in clinical practice. Ratsional’naya farmakoterapiya v kardiologii = Rational pharmacotherapy in cardiology. 2010;6(4):565-568. (In Russ.) doi: 10.20996/1819-6446-2010-6-4-21-25.

29. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D.L., Coca A., de Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S.E., Kreutz R., Laurent S., Lip G.Y.H., McManus R., Narkiewicz K., Ruschitzka F., Schmieder R.E., Shlyakhto E., Tsioufis C., Aboyans V., Desormais I.; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal. 2018;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.

30. Zagidullin N.Sh., Almukhametova G.M., Safina Yu.F., Nigmatullina K. F., Rakhmatullina V. T., Konovalov V. N., Razboeva A. G., Zagidullin S. Z. On the question of optimizing the treatment of arterial hypertension: a combination of an angiotensin-converting enzyme inhibitor and a diuretic. Spravochnik poliklinicheskogo vracha = Handbook of outpatient physician. 2013;(11):27-31. (In Russ.) Available at: https://con-med.ru/magazines/physician/physician-11-2013/k_voprosu_ob_optimizatsii_terapii_arterialnoy_gipertenzii_kombinatsiya_ ingibitora_angiotenzinprevrashch.

31. Chukaev I.I., Spiryakina Ya.G. Indapamide is the retard drug of choice in elderly patients with arterial hypertension. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2013;18(5):56-60. (In Russ.) doi: 10.15829/1560-4071-2013-5-56-60.

32. Ostroumova O.D., Dudaev V.A. Diuretics in the treatment of arterial hypertension: a focus on prolonged action indapamide. Spravochnik poliklinicheskogo vracha = Handbook of outpatient physician. 2010;(10):37-40. (In Russ.) Available at: https://con-med.ru/magazines/ physician/physician-10-2010/diuretiki_v_lechenii_arterialnoy_gipertonii_fokus_na_indapamid_ prolongirovannogo_deystviya.

33. Alekhina O.D., Burlachuk V.T. Clinical example: managing a patient with hypertension on an outpatient basis. Spravochnik poliklinicheskogo vracha = Handbook of outpatient physician. 2013;(3):18-20. (In Russ.) Available at: http://tpacient.ru/articles/160.

34. Yudina I.Yu., Morozova T.E. The clinical use of fixed combinations of antihypertensive drugs. Lechashchiy vrach = Attending doctor. 2015;(2):8. (In Russ.) Available at: https://www.lvrach. ru/2015/02/15436155.